The pharmaceutical company Smith-Kline had purchased the chlorpromazine rights from Rhone-Poulenc in France and had been marketing it as an anti-nausea medication.
Smith-Kline, after purchasing chlorpromazine rights from Rhone-Poulenc in France, began marketing it as an anti-nausea medication.